Phase II DREAMM-2: Belantamab Mafodotin in R/R MM
By
The University of Kansas Cancer Center
FEATURING
Al-Ola Abdallah
By
The University of Kansas Cancer Center
FEATURING
Al-Ola Abdallah
Login to view comments.
Click here to Login